OmicronResearch

Omicron Research

Cell Reports: Structures of Omicron spike complexes and implications for neutralizing antibody development
May.06.2022
Saudi Journal of Biological Sciences: An in silico approach unveils the potential of antiviral compounds in preclinical and clinical trials as SARS-CoV-2 omicron inhibitors
May.02.2022
Biosafety and Health: Genetic differentiation and diversity of SARS-CoV-2 omicron variant in Its early outbreak
Apr.25.2022
American Journal of Obstetrics and Gynecology: Preserved recognition of Omicron Spike following COVID-19 mRNA vaccination in pregnancy
Apr.14.2022
JAMA Network: Vaccine Booster Dose Appears to Reduce Omicron Hospitalizations
Apr.12.2022
The Lancet: Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study
Apr.07.2022
The Lancet: New year, new SARS-CoV-2 variant: Resolutions on genomic surveillance protocols to face Omicron
Feb.12.2022
Clinical Infection in Practice: The emergence of the Omicron variant
Feb.01.2022
The Lancet: COVID-19 vaccine boosters in the Asia-Pacific region in the context of Omicron
Feb.16.2022
Advisory Board: Do omicron-specific boosters work better? What early research suggests
Feb.08.2022
Cell Reports: Cryo-EM structure of the SARS-CoV-2 omicron spike
Feb.07.2022
The Lancet: The allocation of COVID-19 vaccines and antivirals against emerging SARS-CoV-2 variants of concern in East Asia and Pacific region: A modelling study
Feb.03.2022
Cell: T-cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
Feb.03.2022
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose (The Lancet)
The Lancet: Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19
Jan.28.2022
Understanding omicron (NewScientist)
Omicron’s Message on Vaccines: Boosting Begets Breadth (CellPress)
Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals (Journal of Infection)
Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections or vaccinees (Journal of Infection)
Receptor binding and complex structures of human ACE2 to spike RBD from Omicron and Delta SARS-CoV-2 (Journal of Infection)
From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants (Gene)
Genomic perspectives on the emerging SARS-CoV-2 omicron variant (Genomics, Proteomics & Bioinformatics)
The Lancet Voice: Listen to “Vaccination rates and Omicron in London.”
Structural modeling of Omicron spike protein and its complex with human ACE-2 receptor: Molecular basis for high transmissibility of the virus (Biochemical and Biophysical Research Communications)
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant (Cell Press)
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses (Cell Press)
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies ... (International Journal of Infectious Diseases)
The emergence of new SARS-CoV-2 variant (Omicron) and increasing calls for COVID-19 vaccine boosters-The debate continues (Travel Medicine and Infectious Disease)
SARS-CoV-2 B.1.1.529 (Omicron) Variant in the United States (Morbidity and Mortality Weekly Report) via PracticeUpdate

Cookies são usados neste site. Para recusar ou saber mais, visite nosso página de cookies.